{
    "organizations": [],
    "uuid": "d29f6ed4b058a75b9b648dd302098cc4e23aae45",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amneal-launches-methylphenidate-hy/brief-amneal-launches-methylphenidate-hydrochloride-extended-release-tablets-idUSFWN1PV0V3",
    "ord_in_thread": 0,
    "title": "BRIEF-Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 5, 2018 / 12:17 PM / Updated 22 minutes ago BRIEF-Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets Reuters Staff 1 Min Read \nFeb 5 (Reuters) - Impax Laboratories Inc: \n* AMNEAL LAUNCHES METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS, USP (CII) AB-RATED GENERIC FOR CONCERTAÂ® Source text for Eikon: Further company coverage:",
    "published": "2018-02-05T14:17:00.000+02:00",
    "crawled": "2018-02-05T14:32:24.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "launch",
        "methylphenidate",
        "hydrochloride",
        "tablet",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "impax",
        "laboratory",
        "inc",
        "amneal",
        "launch",
        "methylphenidate",
        "hydrochloride",
        "tablet",
        "usp",
        "cii",
        "generic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}